Amgen | Revenu Net



Net Income Changement Date
AbbVie USD 1.29B 1.31B 2025-03
Agios Pharmaceuticals USD -89289000 7.23M 2025-03
ALKERMES USD 22.46M 344.61M 2025-03
Amgen USD 1.73B 1.1B 2025-03
Biogen USD 240.5M 26.2M 2025-03
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Exelixis USD 139.86M 21.89M 2025-01
Genmab DKK 3.84B 2.58B 2024-12
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
Glaxosmithkline GBP 414M 472M 2024-12
Incyte USD 158.2M 43.01M 2025-03
Ionis Pharmaceuticals USD -146938000 42.59M 2025-03
J&J USD 11B 7.57B 2025-03
Merck USD 5.08B 1.34B 2025-03
Moderna USD -971000000 149M 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Novartis USD 2.82B 371M 2024-12
Novartis USD 2.82B 371M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
PTC Therapeutics USD -65886000 40.77M 2024-12
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 1.87B 1.37B 2025-03
Sarepta Therapeutics USD 159.05M 125.44M 2024-12
Takeda JPY 23.79B 68.26B 2024-12
Teva Pharmaceutical Industries USD -217000000 220M 2024-12
Ultragenyx Pharmaceutical USD -133385000 131K 2024-12
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



Amgen Revenu Net - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.